MétaCan
Menu
Back to cohort
Record W3157490260 · doi:10.5489/cuaj.7367

Canadian Urological Association guideline on the management of non-muscle invasive bladder cancer

2021· article· en· W3157490260 on OpenAlexaffvenueabout
Bimal Bhindi, Ronald Kool, Girish S. Kulkarni, D. Robert Siemens, Armen Aprikian, Rodney H. Breau, Fadi Brimo, Adrian Fairey, Christopher A. French, Nawar Hanna, Jonathan I. Izawa, Louis Lacombe, Victor McPherson, Ricardo Rendon, Bobby Shayegan, Alan So, Alexandre R. Zlotta, Peter C. Black, Wassim Kassouf

Bibliographic record

VenueCanadian Urological Association Journal · 2021
Typearticle
Languageen
FieldMedicine
TopicBladder and Urothelial Cancer Treatments
Canadian institutionsSinai Health SystemUniversity of British ColumbiaMcMaster UniversityDalhousie UniversityWestern UniversityMemorial University of NewfoundlandUniversité LavalUniversité de MontréalUniversity of AlbertaUniversity of CalgaryPrincess Margaret Cancer CentreUniversity Health NetworkOttawa HospitalQueen's UniversityMcGill University Health Centre
FundersEuropean Association of Urology
KeywordsMedicineCystoscopyBladder cancerLymphovascular invasionCystectomyUrine cytologyCarcinoma in situCancerGuidelineUrologyUrinary systemOncologyInternal medicinePathology

Abstract

fetched live from OpenAlex

Prognostic factors for recurrence and progression 5.The most important prognostic factors for recurrence and progression of non-muscleinvasive bladder cancer (NMIBC) are stage and grade (LE 2).All patients with bladder cancer should be properly staged and, specifically for NMIBC, reporting grade is paramount for further management decisions (LE 2; strong recommendation).6.Other prognostic factors are age >70yr, large tumour size (≥3cm), multiple tumours, the presence of concomitant carcinoma in situ (CIS), extensive invasion of the lamina propria, prior recurrence rates > 1 per year and status at first assessment after transurethral resection of the bladder tumour (TURBT) (LE 2), as well as lymphovascular invasion (LVI) (LE 3). 7. Aggressive histological variants such as micropapillary, plasmacytoid and sarcomatoid are associated with increased risk of under-staging and progression (LE 3).Pathological review, preferably by a dedicated uro-pathologist, should be considered in settings where variant histology is suspected or atypical tumours are seen during TURBT (e.g., sessile mass) (LE 3; weak recommendation). Risk stratification8. All patients with NMIBC should be stratified according to the risk of both recurrence and progression for adequate patient counselling and treatment planning (LE 2; strong recommendation).The modified CUA risk stratification system is a suitable tool for this purpose. CUAJ -CUA GuidelineBhindi et al Guideline: NMIBC management 4

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.019
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.989
Threshold uncertainty score0.805

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.019
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.003
Bibliometrics0.0030.003
Science and technology studies0.0020.001
Scholarly communication0.0020.001
Open science0.0050.001
Research integrity0.0060.006
Insufficient payload (model declined to judge)0.0150.006

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.264
Teacher spread0.245 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations26
Published2021
Admission routes3
Has abstractyes

Explore more

Same venueCanadian Urological Association JournalSame topicBladder and Urothelial Cancer TreatmentsFrench-language works237,207